Six Months DHEA Treatment in Female Adrenal Failure
Not Applicable
Completed
- Conditions
- Adrenal Insufficiency
- Registration Number
- NCT00471900
- Lead Sponsor
- University of Aarhus
- Brief Summary
DHEA is an adrenal deriven androgen precourser. The impact of DHEA substitution therapy in adrenal failure is unknown as well as the physiologically effects of DHEA is unknown. Effects of physiologically DHEA substitution is investigated in the model of female adrenal failure.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 10
Inclusion Criteria
- Female,
- Adrenal insuficiency,
- Stable and safe anticonception,
- Stable hydrocortison substituation treatment.
Exclusion Criteria
- Neoplastic and thromboembolic disease,
- Diabetes mellitus.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Quality of life parameteres, cardiovascular parameters, bodycomposition, exercise parameters, hormonal and serological parameters, fuel metabolisme. six months
- Secondary Outcome Measures
Name Time Method